Impact of intermittent preventive treatment of malaria in pregnancy with sulfadoxine–pyrimethamine on sexually transmitted and reproductive tract infections: results from a randomized trial in Uganda
Monthly IPTp-SP may reduce the risk of adverse birth outcomes through its activity against C. trachomatis and GBS, highlighting its potential non-malarial benefits.
Authors
- Peter Olwoch (ORCID: https://orcid.org/0000-0002-7396-3348)
- Miriam Nakalembe (ORCID: https://orcid.org/0000-0001-7569-8173)
- Stephanie L. Gaw
- Erin J. dela Cruz (ORCID: https://orcid.org/0000-0002-3380-5353)
- Abel Kakuru (ORCID: https://orcid.org/0000-0001-9941-1309)
- Harriet Adrama
- Jade Benjamin‐Chung (ORCID: https://orcid.org/0000-0003-3631-3132)
- Nida Özarslan (ORCID: https://orcid.org/0000-0003-3235-1238)
- Miriam Aguti (ORCID: https://orcid.org/0009-0005-8885-6931)
- T. J. H. Clark
- John Ategeka
- Bishop Opira
- Philip J Rosenthal
- Bakar Odongo
- Michelle E Roh
- Jimmy Kizza
- Grant Dorsey
- Moses R Kamya
Institutions
- Oregon Health & Science University (US)
- Palo Alto University (US)
- University of California, San Francisco (US)
- University of California System (US)
- Busitema University (UG)
- Reproductive Science Center (US)
- Stanford Health Care (US)
- Infectious Diseases Research Collaboration (UG)
- Chan Zuckerberg Initiative (United States) (US)
- Global Brain Health Institute (US)
- Makerere University (UG)
- University of San Francisco (US)
- Stanford University (US)
Publication Details
- Journal
- International Journal of Epidemiology
- Published
- 2026-01-02
- DOI
- https://doi.org/10.1093/ije/dyag005
- Primary Topic
- Malaria Research and Control
- Type
- article
- Field-Weighted Citation Impact
- 0.00